<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
    <title>Harm Reduction Coalition</title>
    <link>http://www.harmreduction.org/</link>
    <description></description>
  <item>
    <link>http://www.harmreduction.org/article.php?id=961</link>
    <title>HRC Calls for Greater Syringe Access, Federal Action on Hepatitis</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;The Harm Reduction Coalition (HRC), a national health and human rights advocacy group working to reduce drug-related harm, calls on Congress and the Administration to take immediate action to stem the tide of hepatitis B and C infections and chronic liver disease. HRC issues this call in response to a comprehensive new Institute of Medicine (IOM) report, “Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C.”&lt;/div&gt;
</description>
    <pubDate>Mon, 11 Jan 2010</pubDate>
    <guid>http://www.harmreduction.org/article.php?id=961</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=875</link>
    <title>Does cleaning syringes with bleach kill Hep C?</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;Some brief videos that address the effectiveness of cleaning syringes to reduce the risk of contamination of Hepatitis C, Hepatitis B &amp; HIV&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=875</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=853</link>
    <title>Hepatitis C Counseling</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;This Hepatitis C Counseling Manual is written for practitioners who will be providing Hepatitis C testing and discussing risk reduction strategies with active and former drug users.&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=853</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=848</link>
    <title>Guía para Implementar Grupos de Apoyo para Usarios de Drogas con Hepatitis C: Manual Para Facilitadores</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;Esta guía ha sido desarrollada con información colectiva de participantes de programas de intercambio de jeringuillas y proveedores de servicios que trabajan con grupos de apoyo de la hepatitis C (VHC) en la Ciudad de Nueva York.  Juntos hemos reunido algunas de “las mejores practicas” para establecer grupos para personas con VHC basados en reducción de daño.  También ofrecemos a los facilitadores sugerencias prácticas y herramientas creativas para efectivamente mantener un grupo que cumpla con las necesidades únicas y diversas de aquellos que usaron y que aun usan drogas.

(Spanish Version of HCV Support Groups for Drug Users)&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=848</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=847</link>
    <title>Hepatitis C Support Groups For Drug Users:
Facilitator Manual</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;This guide was developed with the collective input of syringe exchange participants and service providers involved in hepatitis C (HCV) support groups throughout New York City.  Together we have compiled some ‘best practices’ for establishing HCV groups within a harm reduction framework. We also offer facilitators practical suggestions and creative tools for effectively maintaining a group that meets the unique and varied needs of drug users.&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=847</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=845</link>
    <title>Entrenamiento para trabajadores y educadores de la hepatitis C: Manual de 3 sesiones para trabajadores de alcance comunitario y educadores en los programas de Intercambio de Jeringuillas</title>
    <description></description>
    <guid>http://www.harmreduction.org/article.php?id=845</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=844</link>
    <title>Frontline Hepatitis C Training: a 3-Session Curriculum For Syringe Exchange Peer Outreach Workers</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;The Frontline Hepatitis C Training introduces basic concepts about outreach work, peer education, and hepatitis C using a standard format. This 3 session training was designed to help syringe exchange peers integrate hepatitis C into their work with current and former drug users. &lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=844</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org//downloads/SFHEP.pdf</link>
    <title>Adult Viral Hepatitis Resource Guide for San Francisco - 2008</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;A resource guide for San Francisco viral hepatitis prevention and care services. &lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org//downloads/SFHEP.pdf</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=822</link>
    <title>Overview of Hepatitis C &amp; Working with Drug Users</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;by Narelle Ellendon,
Sept 2nd, 2008&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=822</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=503</link>
    <title>Standard of Care</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;HRC advocates for the following standards of practice with regard to hepatitis C virus (HCV) and drug users. &lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=503</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=403</link>
    <title>HCV Research</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;This is an introduction to some of the wealth of research on hepatitis C prevention, care, and treatment for injecting drug users. &lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=403</guid>
  </item>

  <item>
    <link>http://www.hepcproject.typepad.com/</link>
    <title>Hepatitis C Project</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;The Hepatitis C Harm Reduction Project was a NYC Council-funded technical assistance project initiated in late 2003 based on advocacy efforts of the Injection Drug User Health Alliance (IDUHA).

From 2003 through 2007, Hepatitis C Project Staff designed and implemented model forms of hepatitis C programming  at New York City’s 13 Syringe Exchange and Expanded Syringe Access Programs (ESAP). These Service Delivery Models include: hepatitis C testing, HAV/HBV vaccination, treatment education and support groups, drug-user led prevention initiatives, and expanded access to care and treatment.&lt;/div&gt;
</description>
    <guid>http://www.hepcproject.typepad.com/</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=201</link>
    <title>NY AIDS Institute HCV Backgound Paper</title>
    <description></description>
    <guid>http://www.harmreduction.org/article.php?id=201</guid>
  </item>

  <item>
    <link>http://www.harmreduction.org/article.php?id=200</link>
    <title>Success in Getting NIH to Change HCV Guidelines for Drug Users</title>
    <description>&lt;div class=&quot;text blurb&quot;&gt;The 1997 NIH HCV Guidelines generated by the Management of Hepatitis C National Institutes Of Health Consensus Development Conference stated that &quot;Treatment of patients who are drinking significant amounts of alcohol or who are actively using illicit drugs should be delayed until these habits are discontinued for at least 6 months.&quot; This effort was successful in changing NIH guidelines.&lt;/div&gt;
</description>
    <guid>http://www.harmreduction.org/article.php?id=200</guid>
  </item>

</channel></rss>
